Abstract
Background
Accommodations with shared washing facilities increase the risks of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection for people experiencing rough sleeping and evidence on what interventions are effective in reducing these risks needs to be understood.
Methods
Systematic review, search date 6 December 2022 with methods published a priori. Electronic searches were conducted in MEDLINE, PubMed, Cochrane Library, CINAHL and the World Health Organization (WHO) COVID-19 Database and supplemented with grey literature searches, hand searches of reference lists and publication lists of known experts. Observational, interventional and modelling studies were included; screening, data extraction and risk of bias assessment were done in duplicate and narrative analyses were conducted.
Results
Fourteen studies from five countries (USA, England, France, Singapore and Canada) were included. Ten studies were surveillance reports, one was an uncontrolled pilot intervention, and three were modelling studies. Only two studies were longitudinal. All studies described the effectiveness of different individual or packages of mitigation measures.
Conclusions
Despite a weak evidence base, the research suggests that combined mitigation measures can help to reduce SARS-CoV-2 transmission but are unlikely to prevent outbreaks entirely. Evidence suggests that community prevalence may modify the effectiveness of mitigation measures. More longitudinal research is needed.
Systematic review registration
PROSPERO CRD42021292803.
Keywords: COVID-19, health policy, homelessness, infection control, systematic review
Introduction
People are defined as sleeping rough if they sleep outside or without adequate shelter.1 A higher prevalence of comorbidities,2 and lower vaccination rates than the general population,3–7 make people experiencing rough sleeping more vulnerable to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections, coronavirus disease 2019 (COVID-19) complications and other nonrespiratory infections such as tuberculosis.8 In March 2020, the ‘everyone in initiative’ was launched to help people experiencing rough sleeping in England to comply with COVID-19 regulations.9 To this aim, additional funding was made available for accommodation providers to provide more single occupancy accommodation or to restructure existing accommodations to make them COVID-19-safe (i.e. allow isolation).
To help people experiencing rough sleeping to better adhere to personal protective measures, the UK government maintains that single-occupancy accommodation should be provided wherever possible.10
However, in some situations, the need for temporary accommodation for people experiencing rough sleeping may exceed single occupancy availability, and communal facilities may still be needed.10,11
Many of the communal accommodations for people who sleep rough in England typically have shared washing facilities, whilst other aspects such as kitchen use or sleeping arrangements may vary.11 Thus, ‘communal accommodation’ for people experiencing rough sleeping within England can be defined as accommodations that have shared washing facilities (e.g. bathrooms).
Communal accommodation increases the risk of COVID-19 outbreaks,12,13 which are defined as two or more test-confirmed cases associated with a specific context within 14 days.14 Hence, when communal accommodation is the only option, promotion of vaccinations, improved ventilation, mask-wearing, limiting close contact and frequent hand washing are recommended by the UK government.10 However, during the pandemic, most communal accommodations in England were closed;15 therefore, the effectiveness of these measures in communal accommodations is unclear. Understanding the efficacy of mitigation strategies in this setting is essential for effective future planning and implementation of guidance and policies intending to protect people experiencing rough sleeping against COVID-19 and other infections. This paper thus systematically reviews the international evidence on the effectiveness of measures to prevent the spread of SARS-CoV-2 infection in accommodations for people experiencing rough sleeping that have shared washing facilities.
Methods
This systematic review followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines16 and was registered with PROSPERO. Review protocol registration number: CRD42021270053.
Search strategy, selection criteria and screening process
Five electronic databases: MEDLINE, PubMed, Cochrane Library, CINAHL and the WHO COVID-19 Database were searched from database establishment to the 6 December 2022. By combining ‘COVID-19’, ‘transmission’ and ‘setting or population’ terms, searches were restricted to research that investigated SARS-CoV-2 transmission mitigation strategies in communal accommodations for people experiencing rough sleeping.
All study designs that quantitatively assessed the effectiveness of measures to protect against SARS-CoV-2 infections and COVID-19 complications in people experiencing rough sleeping in communal accommodation were included. Shared washing facilities are a common feature of ‘communal accommodation’ for people experiencing rough sleeping in England.13 Thus, only studies that evaluated mitigation measures in accommodations that met this definition were included. Although the structure of ‘communal accommodation’ may differ across countries this review aimed to evaluate the effectiveness of mitigation measures in settings similar to the provisions in England. Consequently, when evaluating the effectiveness of interventions in communal accommodation for people experiencing rough sleeping all other structural characteristics (e.g. sleeping arrangements) were considered as mitigation measures. We included modelling studies, surveillance reports, pilot studies and randomized control trials (RCTs), and excluded media articles, reviews and opinion papers. A detailed description of inclusion criteria, search strategies and terms is available in the registered PROSPERO protocol. The final search strategy did not deviate from the protocol.
Database searching was accompanied by grey literature searches and hand searching of reference lists of identified studies and publication lists of known experts. Lead researchers of ongoing relevant RCTs were contacted for potential preliminary reports or findings by the principal investigator. Title, abstract and full-text screening of all identified records were conducted independently and in duplicate by two researchers with almost perfect agreement (95%; Cohen’s k = 0.88) and discrepancies were resolved through discussion.
Risk of bias assessment and data extraction
Two researchers independently assessed the risk of bias for each study using appraisal tools from the Joanna Briggs Institute (JBI).17 Two reviewers independently and in duplicate rated each domain and computed an overall risk of bias rating for each study (low, moderate and high). Discrepancies were resolved through discussions with consensuses reached on all records. Due to the anticipated low number of available literature in this review, no predefined exclusion quality cut-off was used.
Using a pre-defined and previously used12 Excel spreadsheet, the following information was extracted for all retained records: the first author with publication year, study design, study setting/country, target population/sample, mitigation measures assessed, outcomes measured including date measured and method used and main findings. Data extraction was completed independently and in duplicate by two researchers and subsequently combined, and discrepancies were independently checked by a third researcher.
Data analysis and synthesis
Due to the heterogeneity in the mitigation strategies assessed, the conceptualization of mitigation approaches and how the outcomes were reported across studies, meta-analysis was not possible here and a narrative thematic analysis was conducted. The results were organized by intervention type.
Results
Study characteristics
We identified 883 records, including 186 duplicates through database searching. 697 unique abstracts were screened and assessed for eligibility by two researchers in duplicate, of which 650 were excluded. The remaining 47 records and the 18 identified from other sources (65 in total) were sought for full-text screening. 51 articles were excluded at this stage; 43 for not assessing the effectiveness of mitigation measures and another 8 because they did not meet our definition of communal accommodation for people experiencing rough sleeping.18–25 The remaining 14 articles were included in this review (Fig. 1).
Fig. 1.
PRISMA search flow diagram.
Studies were conducted in the United States (USA), England, France, Singapore and Canada. Two studies26,27 were longitudinal. Ten studies were surveillance reports,20,26–34 one was a pilot intervention report35 three were modelling or simulation studies.36–38 All studies began their surveillance between March and April 2020, capturing the peak of the first wave of the COVID-19 pandemic and before vaccine rollouts in their respective countries.39–42 Homelessness was defined inconsistently across the included studies. Nine studies included samples that contained only staff and/or residents within shelters, hostels and hotels used as emergency accommodations for people experiencing homelessness. The other five studies included additional accommodation types (e.g. squats) and/or groups of people that are living in precarious conditions (e.g. migrant workers). See Table 1, for a summary of included studies.
Table 1.
Characteristics of synthesized studies
| Characteristic | Number of studies |
|---|---|
| Study design | |
| Cross-sectional | 12 |
| Longitudinal | 2 |
| Study type | |
| Modelling/Simulation | 3 |
| Pilot intervention | 1 |
| Surveillance report | 10 |
| Country of study | |
| United State of America (USA) | 6 |
| England | 1 |
| France | 4 |
| Singapore | 1 |
| Canada | 2 |
| Outcomes* | |
| Infection incidence/transmission risk or rate | 13 |
| Number of and severity of outbreaks | 2 |
| Hospital admissions/bed use | 3 |
| The severity of infections/death | 1 |
| Population | |
| Staff/residents in shelters/hostels/hotels for homeless people | 9 |
| Includes other accommodation and/or sub-groups of people | 5 |
* For studies that reported on multiple outcomes, each of the outcomes was tabulated separately in this table.
Risk of bias
The risk of bias was rated as low in three studies,26,36,38 moderate in eight studies,20,27,29–31,34,35,37 and high in three studies.28,32,33 The risk of bias for each study is presented in Tables 2 and 3.
Table 2.
Summary of synthesized surveillance studies
| Reference, Country | Study design, and duration | Mitigation measure(s) | Sample | Outcome measure (s) | Summary of findings | Risk of bias |
|---|---|---|---|---|---|---|
| O’Shea et al., 202135 Hamilton, Canada |
Cross-sectional uncontrolled pilot intervention 17 March –30 April 2020 |
Opening of surge shelters, on-site rapid symptomatic testing, and available isolation space | 8 Shelters: 104 residents, and 141 staff | Incidence | 1% of residents and 5% of staff tested positive for COVID-19 compared with an estimated prevalence of 5–7% in the local community | Moderate |
| Tan and Chua, 202028 Singapore (Nationwide) |
Cross-sectional surveillance report March 2020 |
Increased bed spacing (1 metre apart). Opening of surge shelters, and staggered meal/shower times | 35 shelters: serving 700 residents | Reported Outbreaks | No known outbreaks were reported in homeless shelters in March 2020 | High |
| Husain et al., 202129 Paris, France |
Cross-sectional surveillance report 1 March–31 May 2020 |
Sleeping arrangements | Residents from 3 shelters | Hospitalization risk, and incidence | The estimated risk of hospitalization did not differ with the number of residents sharing a room. The drop-in day centre had higher infection rates than the healthcare centres (90.6% versus 63.2%, P = 0.0042) | Moderate |
| Chang et al., 202227 Chicago, USA |
Longitudinal surveillance report 30 March –6 May 2020 |
Cleaning, Hand sanitizer, universal mask-wearing, daily temperature and symptom screening, on-site isolation, off-site isolation, lockdown on-site, and universal PCR-testing | 1 shelter: 445 residents and staff | Incidence | The inclusion of increased hygiene, frequent site cleaning, universal mask-wearing, three times weekly PCR testing, and off-site isolation reduced new cases from 45% on the 8 April 2020 to 11% in 16 April and 28 April 2020 and 1% in May 2020 | Moderate |
| Loubiere et al., 202130 Marseille, France |
Cross-sectional surveillance report 1 June–5 August 2020 |
Sleeping arrangements, and resident transience | 48 rough sleeping locations: 1156 people experiencing rough sleeping | Incidence | Private rooms and shared rooms showed a similar incidence (5.31% versus 5.67%, respectively, P = 0.896), less than a month in emergency shelters was associated with a lower incidence (3.61% versus 10.57%, P < 0.001) and changing accommodation showed no change (7.01% versus 4.52, P = 0.08) | Moderate |
| Roederer et al., 202131 Paris and Seine-Saint-Denis, France |
Cross-sectional surveillance report 23 June–2 July 2020 |
Composite close contacts score containing: sleeping arrangements, and bathroom and kitchen sharing | 10 emergency shelters and hotels, 1 food distribution site, and 1 migrant worker dormitory: 818 (124 migrant workers). | Incidence | Reducing the amount of time that residents spent in close contact with others (15 minutes or more within 1 metre) was associated with lower odds of being seropositive (Medium: OR = 2.7 (1.5–5.1), High: OR = 3.4 (1.7–6.9) | Moderate |
| Ly et al., 202126 Marseille, France |
Longitudinal surveillance report 26 March–5 November 2020 |
Increase to 24-hour operation, relocation of some residents to hotels, universal mask-wearing, frequent handwashing, and improved coughing etiquette | 4 shelters (only 3 had follow-ups): 646 residents 411 homeless, 77 asylum seekers, 58 people living in precarious conditions) and 152 staff | Incidence | Following the implementation of mitigation measures all three shelters that received follow-up assessments showed lower incidence (down to 1.1% from 20.6% by the end of the study). Mitigation measures helped to keep infection rates lower during the second wave in France (7.1% compared with 20.6% in the first wave | Low |
| Karb et al., 202032 Rhode Island, USA |
Cross-sectional surveillance report 19 April–24 April 2020 |
Increased bed spacing (6 feet apart), daily symptom screening, universal mask-wearing, daily updates and resident transience | 5 shelters: 229 residents | Incidence | Shelters that prohibited new residents showed no cases of COVID-19. Other shelters that allowed new residents showed that residents that stayed for 14 days or more in the same shelter were less likely to contract COVID-19. | High |
| Rogers et al., 202133 Washington, USA |
Cross-sectional surveillance report 1 Jan–24 April 2020 |
Sleeping arrangements | 14 shelters: 1434 encounters/tests | Incidence | Higher positivity rates were found in residents that slept in a communal room or space (2.3%) compared with those that slept in private spaces (1.38%). 86% of all identified cases were in participants who slept in a communal space in the past week (versus 14% in private rooms) | High |
| Self et al., 202134 USA (7 states) |
Cross-sectional surveillance report 30 March –1 June 2020 |
21 Individual mitigation measures (some shelters may implement multiple simultaneously) | 63 shelters: Median number of residents per shelter is 63 (range = 7–364) | Prevalence: High (>2.9%) Very high (>10%) |
Shelters that positioned beds in a head-to-toe sleeping position and excluding symptomatic staff from working were less likely to have a high infection prevalence, and Shelters that provided medical services available were less likely to have a very high infection prevalence. | Moderate |
| Kiran et al., 202120 Toronto, Canada |
Repeated cross-sectional surveillance report 1 April–31 July 2020 |
Resident transience | 20 shelters: 872 residents | Incidence | Shelter residents who tested positive were less likely to have visited another shelter in the last 14 days (0% versus 18%, P < 0.01). | Moderate |
Table 3.
Summary of synthesized modelling studies
| Reference, Country | Mitigation measure(s) | Calibration data | Outcome measure(s) | Simulation effect estimates | Risk of bias |
|---|---|---|---|---|---|
| Baggett et al., 202036 Boston, USA |
7 different combinations of daily symptom screening, PCR testing for symptomatic residents and staff, Universal PCR testing, and isolation in other accommodations | Data from 2019 that included 2258 residents from homeless shelters | Incidence, hospital bed use, and total days in hospital | Universal PCR testing every 2 weeks and isolation in an alternative care site was found to be the most effective and cost effective strategy: R0 = 2.6: 14% fewer infections, 86% lower hospital bed use, and 84% less hospital days R0 = 1.3: 62% fewer infections, 89% lower hospital bed use, and 96% less hospital days R0 = 0.9: 46% fewer infections, 80% lower hospital bed use, and 90% less hospital days |
Low |
| Lewer et al., 202037 England (Nationwide) |
Private bedroom and washroom facilities, isolation in other accommodations, lockdown in accommodation, closure of communal spaces, hand hygiene promotion, and physical distancing | Data from March 2020 that included 46 565 residents experiencing homelessness (35 817 living in 1065 hostels for homeless people, 3616 sleeping in 143 night shelters, and 7132 sleeping outside) | Incidence, hospital admissions, deaths, and ICU admissions |
Wave 1: 21 092 fewer cases (45.3% reduced cumulative incidence), 92% fewer hospital admissions, 92% fewer deaths, and 91% fewer ICU admissions. Wave 2: 11 168 fewer cases (24.0% reduced cumulative incidence), 89% fewer hospital admissions. 89% fewer deaths, and 89% fewer ICU admissions. |
Moderate |
| Chapman et al., 202138 Boston, San Francisco, and Seattle, USA |
Daily symptom screening, twice-weekly PCR, universal masking, and relocation of some residents to hotels | Data from PCR testing during 28 March–10 April 2020 conducted in 5 Shelters (1 in San Francisco, 1 in Boston, and 3 in Seattle) on 788 residents and 137 staff. | Incidence, and probability of averting an outbreak |
Incidence reduction: Community incidence = 0: R0 = 1.5 = 96%; R0 = 2.9 = 97%; R0 = 3.9 = 98%; R0= 6.2 = 92% Community incidence = 122/1 M/day: R0 = 1.5 = 72%; R0 = 2.9 = 90%; R0 = 3.9 = 92%; R0 = 6.2 = 88% Community incidence = 260/1 M/day: R0= 1.5 = 66%; R0 = 2.9 = 86%; R0 = 3.9 = 90%; R0= 6.2 = 79% Community incidence = 439/1 M/day: R0= 1.5 = 63%; R0 = 2.9 = 84%; R0= 3.9 = 86%; R0= 6.2 = 75% Probability of averting an outbreak: R0 = 1.5: OR = 0.74 (95% CI = 0.40–1.00) R0 = 2.9: OR = 0.42 (95% CI = 0.13–0.99) R0 = 3.9: OR = 0.29 (95% CI = 0.07–0.97) R0 = 6.2: OR = 0.19 (95% CI = 0.02–0.91) |
Low |
Bolded and italicized values refer to the SARS-CoV-2 Reproduction number (Ro).
Study findings
Individual interventions
Eight cross-sectional studies report the effectiveness of individual interventions, including single occupancy rooms, resident mobility, physical distancing between residents and exclusion of symptomatic staff.20,28–34 Despite reporting the efficacy of each intervention independently, not all mitigation measures were implemented in isolation (see Table 2 for more details).
The effectiveness of sleeping in single occupancy rooms and restricting resident mobility is inconsistent. Two reports from France found that sleeping in communal rooms was not associated with a higher SARS-CoV-2 infection rate or risk of hospitalization compared with sleeping in a private room,29,30 whereas in the USA sleeping in communal rooms was associated with higher rates of positivity compared with those sleeping in a private room.33 Similarly, the effects of resident mobility varied. In a surveillance report from Canada, residents who remained in the same accommodation for 14 days were less likely to test positive.20 Conversely, in a report from France changing accommodations showed no relationship with odds of being seropositive compared with not changing accommodations.30 In France, spending less than a month in emergency shelters was associated with lower odds of being seropositive (compared with more than a month).30 In a report of six US shelters, despite implementing multiple other infection control practices (see Table 2 for details) only accommodations that prohibited new residents reported no outbreaks.32
Measures reducing contact between residents also showed conflicting results. A report in France found that limiting the frequency that residents spent more than 15 min within 1 m of other residents and staff was associated with lower odds of being seropositive.31 The study reduced close contact by reducing the number of residents sharing sleeping, cooking and washing facilities. Compared with having 5 or fewer close contacts, more close contacts were associated with greater odds of testing positive for SARS-CoV-2 (6–9 close contacts: OR = 2.7, 95% CI = 1.5–5.1 and >10 close contacts: OR = 3.4, 95% CI = 1.7–6.9). This is consistent with a report from Singapore that suggested there were no reported outbreaks in homeless shelters that had increased bed spacing and staggered meal and shower times.28 However, because no further information was available in these studies it is unclear precisely how physical distancing was defined in these contexts. On the other hand, a cross-sectional surveillance report of sixty-three shelters across seven states in the USA found that increasing bed spacing to 3 feet apart and filling fewer than 74% of beds was not associated with lower SARS-CoV-2 prevalence.34 Instead, positioning beds head-to-toe and excluding symptomatic staff from working was associated with reduced odds of reporting SARS-CoV-2 prevalence above 2.9% (the median of the 7-day average of the six counties in the study). However, it is not clear whether these shelters implemented head-to-toe sleeping and/or excluded symptomatic staff from working individually or simultaneously with other measures.
Combined measures
A cross-sectional uncontrolled pilot study35 and two longitudinal studies26,27 looked at a combination of measures to reduce SARS-CoV-2 transmission risk.
The strongest available evidence comes from a longitudinal report (with a low risk of bias) of four shelters (and associated hotels used for depopulation) in France that were assessed from March to November 2020.26 In this report, reducing the density of communal accommodation, encouraging good hygiene practices, and increasing social distancing helped to reduce the SARS-CoV-2 infection rate and helped to keep infection rates lower during subsequent waves of SARS-CoV-2, but did not prevent infections entirely. The study reported a decline from 21% of infected residents during the first wave of SARS-CoV-2 (March 2020) to 7% in the middle of the second wave (September 2020), following the implementation of the suggested mitigation measures.26 Similarly, a report from the USA revealed that increased accommodation cleaning, more frequent hand washing, universal mask-wearing, off-site isolation, daily symptom screening, PCR testing three times per week, and prohibiting residents who left the accommodation to return was found to reduce the SARS-CoV-2 infection rate from 45% of infected residents in April 2020 to less than 1% in May 2020.27
A Canadian uncontrolled pilot study35 suggests that by reducing shelter density, increasing social distancing, providing rapid on-site testing, universal mask-wearing and providing an isolation area for people awaiting test results the researchers were able to keep shelter SARS-CoV-2 infection rates at 1%, which was below that of the general population (estimated 5–7%), but could not entirely stop new infections within the shelter.
Modelling studies
Three modelling studies were selected: two simulating shelters in the USA (both rated as having a low risk of bias)36,38 and in England37 (summarized in Table 3).
Both US studies estimated that daily symptom screening, relocation of some residents to hotels (to reduce shelter density), universal mask-wearing, off-site isolation and twice weekly PCR testing could help to reduce SARS-CoV-2 infections by between 62%36 and 96%38 when the reproduction number (R0) is low (R0 = 1.3 and 1.5, respectively). Under a low R0, it was estimated that together these mitigation measures had a 74% chance to avert an outbreak in the communal accommodation; however, as the community prevalence increases (to 2.9, 3.9 and 6.2), the effectiveness of these mitigation measures to prevent an outbreak declined to 42%, 29% and 19%, respectively.38 The simulation in England also estimated that combined packages of interventions could help dramatically reduce infection rates by 45% and hospitalizations by 92% during the first wave of COVID-19 in the country, but during the second spike in community prevalence, whilst the measures were still in place the estimated effectiveness dropped to a reduction of 24% in SARS-CoV-2 infections and 89% fewer hospitalizations.
Discussion
Main findings
Existing evidence on the effectiveness of interventions to reduce SARS-CoV-2 transmission and COVID-19 complications among people experiencing homelessness in communal accommodation is weak, due to a reliance on cross-sectional study design and modelling studies as well as the risk of bias in study methodologies. However, the evidence shows that the implementation of multiple mitigation measures together can help reduce SARS-CoV-2 infections in communal accommodations, although not enough to stop all outbreaks. The pilot intervention in Canada35 and the longitudinal surveillance report in France26 provided the strongest evidence upon which to assess mitigation measures in this setting. Yet, many of the other studies lacked the critical information required to understand and assess the implemented interventions. Continued and better quality research into how to mitigate COVID-19 and other diseases in communal accommodation is needed, particularly taking into account how factors such as the prevalence of SARS-CoV-2 in the community can influence the effectiveness of mitigation measures.
What is already known
Communal accommodation is well recognized to increase the risk of transmission of SARS-CoV-212 and could accelerate the spread of other airborne pathogens, such as TB.8 Severe complications from COVID-19 and TB are far more pronounced in vulnerable populations that have increased comorbidities and are under-vaccinated, such as people experiencing rough sleeping, migrant workers and refugees and asylum seekers.2,43,44 Differing physical, social, economic and environmental factors increase the susceptibility to hazards for each of these populations,45 which are further exacerbated by poor living conditions.46 Thus, because it is precisely these populations that often reside in precarious housing or are living in overcrowded or communal accommodations (e.g. migrant processing centres, night shelters),47 understanding how to protect these vulnerable populations from life-threatening diseases in communal accommodations is crucial.
What this study adds
This review adds to the previous literature by compiling the available international evidence to assess the effectiveness of COVID-19 mitigation strategies in communal accommodations for people experiencing rough sleeping. The findings from this review suggest that implementing multiple mitigation measures simultaneously, such as early identification and isolation of positive cases, reducing accommodation density, reducing close contacts and promoting better hygiene and mask-wearing, could under some circumstances help reduce SARS-CoV-2 transmission in communal settings. Similar mitigation measures have been shown to help reduce the spread of SARS-CoV-2 in schools48 and shelters for asylum seekers49 and other airborne transmissible conditions, like TB50 and influenza.51
However, this review also exposes the weakness of the available evidence concerning assessing the effectiveness of COVID-19 mitigation measures in communal accommodations for people experiencing rough sleeping. The literature is made up of mostly cross-sectional studies that were conducted during the first wave only and before vaccine rollouts in their respective locations. Because vaccine uptake is lower in people experiencing rough sleeping6 and some evidence suggests that there is still transmission in communal settings following vaccination,52 it is increasingly important to understand what interventions are effective at reducing transmission risks in communal accommodations for people experiencing rough sleeping. However, with most of the available evidence being cross-sectional and many with a high risk of bias, more high-quality research that allows causality to be determined is needed to help in identifying the measures that are the most effective.
Furthermore, despite the recognition that good ventilation is likely to play a role in protecting people in communal accommodation against SARS-CoV-2, TB and Influenza,10,50,51 no studies captured in this review assess ventilation as a mitigation measure in communal accommodation for people experiencing rough sleeping.
Finally, this review demonstrates that factors such as community prevalence can influence how effective different mitigation measures are. For instance, a modelling study estimated that universal mask-wearing on its own would reduce the infection rate in the shelter by 86% when the community prevalence was low, but only by 56% when community infection rates were high. This is important because during periods of low community prevalence individual mitigation measures may be sufficiently effective. France and Canada’s national lockdown was stricter than in the USA,53 where large social and religious gatherings still occurred.54 Thus, national policies and behaviours and attitudes of residents in the surrounding communities may also influence the effectiveness of mitigation measures.
Limitations of study
There are, however, some caveats of this review that need to be considered. To begin with, this review did not include pre-print servers which may have resulted in some available evidence being missed. Additionally, the study designs of the literature captured by this review are too limited to allow concrete recommendations on individual mitigation measures for policymakers and accommodation providers to be provided. Finally, variability in the types of communal accommodations reported on and the country-level differences in the COVID-19 landscapes in the captured studies make relating the findings from this review to the UK setting more difficult.
Conclusions
This review reveals that the available evidence to assess the effectiveness of COVID-19 mitigation strategies in communal accommodations for people experiencing rough sleeping is weak. Yet, together it suggests that even though no intervention or ‘package of interventions’ is likely to prevent outbreaks, they can be used to reduce SARS-CoV-2 infections and COVID-19 complications in this setting. Combining the opening of additional accommodations to reduce the density in communal shelters, universal mask-wearing and proper hygiene practices (i.e. hand washing, less face touching, and good coughing etiquette) may help reduce infection rates in communal accommodations for people experiencing rough sleeping. However, the evidence also suggests that situational factors such as community prevalence will play a role in the efficacy of implemented mitigation packages. It is unclear whether other individual or combinations of mitigation strategies not assessed here could prevent outbreaks or further reduce infection risks in communal accommodations for people experiencing rough sleeping. Thus, better quality research is urgently needed in this area.
Conflict of interest
There are no conflicts of interest to declare.
Funding
This research did not receive any specific grant from funding agencies in the public, commercial or not-for-profit sectors.
Authors’ contributions
SH contributed to the design of this research and participated in literature searching, data extraction, data synthesis/analysis, manuscript preparation, and reviewing and editing. OC participated in literature searching, data extraction, data synthesis/analysis, manuscript preparation, and reviewing and editing. MX and JS contributed to the design of the research and manuscript preparation and editing. RC, EP, and JL participated in research design and manuscript editing. ICM was responsible for the supervision of the entire project and participated in the design of the research and reviewing and editing of the manuscript.
Steven Haworth, Research Officer
Owen Cranshaw, Research Assistant
Mark Xerri, Programme Manager: Rough Sleeping Drug & Alcohol Treatment
Jez Stannard, Senior Programme Manager: Rough Sleeping Drug & Alcohol Treatment
Rachel Clark, Head of Evidence and Evaluation
Emma Pacey, Policy Lead for Inclusion Health
Gill Leng, National Health and Homelessness Adviser
Ines Campos-Matos, Deputy Director for Inclusion Health
Contributor Information
Steven Haworth, Addictions and Inclusion Directorate, Office for Health Improvement and Disparities, London SW1H 0EU, UK; Institute for Social and Economic Research, University of Essex, Essex CO4 3SQ, UK.
Owen Cranshaw, Institute for Social and Economic Research, University of Essex, Essex CO4 3SQ, UK.
Mark Xerri, Addictions and Inclusion Directorate, Office for Health Improvement and Disparities, London SW1H 0EU, UK.
Jez Stannard, Addictions and Inclusion Directorate, Office for Health Improvement and Disparities, London SW1H 0EU, UK.
Rachel Clark, Policy, Systems and Innovations Directorate, Office for Health Improvement and Disparities, London SW1H 0EU, UK.
Emma Pacey, Addictions and Inclusion Directorate, Office for Health Improvement and Disparities, London SW1H 0EU, UK.
Gill Leng, Addictions and Inclusion Directorate, Office for Health Improvement and Disparities, London SW1H 0EU, UK.
Ines Campos-Matos, Addictions and Inclusion Directorate, Office for Health Improvement and Disparities, London SW1H 0EU, UK.
References
- 1. Cream J, Fenney D, Williams E et al. Delivering Health and Care for People Who Sleep Rough: Going above and Beyond. London: The Kings Fund, 2020. [Google Scholar]
- 2. Nichols G, Mays M. Supporting and protecting residents experiencing homelessness in the Nation’s largest cities during COVID-19. J Public Health Manag Pract JPHMP 2021;27 Suppl 1, COVID-19 and Public Health: Looking Back, Moving Forward:S57–62. 10.1097/PHH.0000000000001287. [DOI] [PubMed] [Google Scholar]
- 3. Shariff SZ, Richard L, Hwang SW et al. COVID-19 vaccine coverage and factors associated with vaccine uptake among 23 247 adults with a recent history of homelessness in Ontario, Canada: a population-based cohort study. Lancet Public Health 2022;7(4):e366–77. 10.1016/S2468-2667(22)00037-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4. Platt L, Rathod SD, Cinardo P et al. Prevention of COVID-19 among populations experiencing multiple social exclusions. J Epidemiol Community Health 2022;76(2):107–8. 10.1136/jech-2021-216889. [DOI] [PubMed] [Google Scholar]
- 5. Office for National Statistics . Dataset: Barriers to COVID-19 Vaccination. London: Office for National Statistics; 2021. https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/healthandwellbeing/datasets/barrierstocovid19vaccination (29 July 2022, date last accessed). [Google Scholar]
- 6. Paudyal V, Racine M, Hwang SW. COVID-19 vaccination amongst persons experiencing homelessness: practices and learnings from UK, Canada and the US. Public Health 2021;199:e2–3. 10.1016/j.puhe.2021.08.015. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. UK Health Security Agency . Promotional Material: Vaccine Update: Issue 330. London: UK Health Security Agency, 2022, COVID-19 spring special edition. Published June 2022. https://www.gov.uk/government/publications/vaccine-update-issue-330-june-2022-covid-19-spring-special-edition/vaccine-update-issue-330-june-2022-covid-19-spring-special-edition (31 August 2022, date last accessed).
- 8. Public Health England, Homeless Link . Tuberculosis (TB) and Homelessness: Information for Homelessness Sector Staff. London: Public Health England, 2019. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/851820/RA_TB__Homelessness_-_staff.pdf (8 December 2022, date last accessed). [Google Scholar]
- 9. Cromarty H. Coronavirus: Support for Rough Sleepers (England). London: House of Commons, 2021, 37. https://researchbriefings.files.parliament.uk/documents/CBP-9057/CBP-9057.pdf (21 February 2022, date last accessed). [Google Scholar]
- 10. Department for Levelling Up, Housing and Communities . Guidance: Operating Principles for Night Shelters. London: The Department of Levelling Up Housing and Communities, September 2022. https://www.gov.uk/guidance/operating-principles-for-night-shelters (31 August 2022, date last accessed).
- 11. HomeLess Link . SWEP and Cold Weather 2020 Guidance . London: Homeless Link, 2020. https://www.homeless.org.uk/sites/default/files/site-attachments/SWEP%20and%20cold%20weather%202020%20guidance.pdf (18 December 2022, date last accessed). [Google Scholar]
- 12. Public Health England . Risk of COVID-19 Transmission in Communal Rough Sleeping Accommodation: A Rapid Evidence Review. Public Health England, 2020, 19. [Google Scholar]
- 13. Homeless Link . SWEP Guidance 2020–21: Planning of SWEP and Extended Winter Provision for People Sleeping Rough During Covid-19. Homeless Link, 2020. https://www.homeless.org.uk/sites/default/files/site-attachments/SWEP%20and%20cold%20weather%202020%20guidance.pdf (23 December 2021, date last accessed). [Google Scholar]
- 14. UK Health Security Agency . Guidance COVID-19: Epidemiological Definitions of Outbreaks and Clusters in Particular Settings. Gov.uk, August 2020. https://www.gov.uk/government/publications/covid-19-epidemiological-definitions-of-outbreaks-and-clusters/covid-19-epidemiological-definitions-of-outbreaks-and-clusters-in-particular-settings (22 February 2022, date last accessed). [Google Scholar]
- 15. Story A, Hayward AC. Public Health Rationale for NOT Opening/Re-Opening Communal Airspace Sleeping Facilities for Homeless People during the SARS-CoV-2 Pandemic. London: Faculty for Homelessness and inclusion Health, 2020. https://www.pathway.org.uk/wp-content/uploads/UCL-CCIH-Faculty-Position-Statement-Aug-2020-Communal-Airpsace-Sleeping-Facilities-AS-AH.pdf (27 May 2023, date last accessed). [Google Scholar]
- 16. Page MJ, McKenzie JE, Bossuyt PM et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021;372:n71. 10.1136/bmj.n71. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17. Joanna Briggs Institute . Critical Appraisal Tools. Adelaide: Joanna Briggs Institute, 2021. https://jbi.global/critical-appraisal-tools (18 December 2021, date last accessed).
- 18. Fields VL, Kiphibane T, Eason JT et al. Assessment of contact tracing for COVID-19 among people experiencing homelessness, Salt Lake County Health Department, March–May 2020. Ann Epidemiol 2021;59:50–5. 10.1016/j.annepidem.2021.04.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. Fujita M, Matsuoka S, Kiyohara H et al. “Staying at home” to tackle COVID-19 pandemic: rhetoric or reality? Cross-cutting analysis of nine population groups vulnerable to homelessness in Japan. Trop Med Health 2020;48:1–12. 10.1186/s41182-020-00281-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20. Kiran T, Craig-Neil A, Das P et al. Factors associated with SARS-CoV-2 positivity in 20 homeless shelters in Toronto, Canada, from April to July 2020: a repeated cross-sectional study. CMAJ Open 2021;9(1):E302–8. 10.9778/cmajo.20200253. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21. Loutfy M, Kennedy VL, Riazi S et al. Development and assessment of a hospital-led, community-partnering COVID-19 testing and prevention program for homeless and congregate living services in Toronto, Canada: a descriptive feasibility study. CMAJ Open 2022;10(2):E483–90. 10.9778/cmajo.20210105. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22. McCormick D, Scott T, Chavez J et al. LB-12. SARS-CoV-2 RNA and antibodies among people experiencing homelessness and staying in shelters or outdoor encampments in Denver, Colorado, May–July 2020. Open Forum Infect Dis 2020;7:S849–50. 10.1093/ofid/ofaa515.1909. [DOI] [Google Scholar]
- 23. Montgomery MP, Paulin HN, Morris A et al. Establishment of isolation and noncongregate hotels during COVID-19 and symptom evolution among people experiencing homelessness—Atlanta, Georgia, 2020. J Public Health Manag Pract JPHMP 2021;27(3):285–94. 10.1097/PHH.0000000000001349. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24. Montgomery MP, Hong K, Clarke KEN et al. Hospitalizations for COVID-19 among US people experiencing incarceration or homelessness. JAMA Netw Open 2022;5(1):e2143407. 10.1001/jamanetworkopen.2021.43407. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25. Tobolowsky FA, Gonzales E, Self JL et al. COVID-19 outbreak among three affiliated homeless service sites—King County, Washington, 2020. MMWR Morb Mortal Wkly Rep 2020;69(17):523–6. 10.15585/mmwr.mm6917e2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26. Ly TDA, Nguyen NN, Hoang VT et al. Screening of SARS-CoV-2 among homeless people, asylum-seekers and other people living in precarious conditions in Marseille, France, March–April 2020. Int J Infect Dis 2021;105:1–6. 10.1016/j.ijid.2021.02.026. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27. Chang YS, Mayer S, Davis ES et al. Transmission dynamics of large coronavirus disease outbreak in homeless shelter, Chicago, Illinois, USA, 2020. Emerg Infect Dis 2022;28(1):76–84. 10.3201/eid2801.210780. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28. Tan LF, Chua JW. Protecting the homeless during the COVID-19 pandemic. Chest 2020;158(4):1341–2. 10.1016/j.chest.2020.05.577. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29. Husain M, Rachline A, Cousien A et al. Impact of the COVID-19 pandemic on the homeless: results from a retrospective closed cohort in France (March–May 2020). Clin Microbiol Infect 2021;27(10):1520.e1–5. 10.1016/j.cmi.2021.05.039. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30. Loubiere S, Monfardini E, Allaria C et al. Seroprevalence of SARS-CoV-2 antibodies among homeless people living rough, in shelters and squats: a large population-based study in France. PloS One 2021;16(9):e0255498. 10.1371/journal.pone.0255498. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31. Roederer T, Mollo B, Vincent C et al. Seroprevalence and risk factors of exposure to COVID-19 in homeless people in Paris, France: a cross-sectional study. Lancet Public Health 2021;6(4):e202–9. 10.1016/S2468-2667(21)00001-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32. Karb R, Samuels E, Vanjani R et al. Homeless shelter characteristics and prevalence of SARS-CoV-2. West J Emerg Med 2020;21(5):1048–53. 10.5811/westjem.2020.7.48725. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33. Rogers JH, Link AC, McCulloch D et al. Characteristics of COVID-19 in homeless shelters: a community-based surveillance study. Ann Intern Med 2021;174(1):42–9. 10.7326/M20-3799. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34. Self JL, Montgomery MP, Toews KA et al. Shelter characteristics, infection prevention practices, and universal testing for SARS-CoV-2 at homeless shelters in 7 US urban areas. Am J Public Health 2021;111(5):854–9. 10.2105/AJPH.2021.306198. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35. O’Shea T, Bodkin C, Mokashi V et al. Pandemic planning in homeless shelters: a pilot study of a coronavirus disease 2019 (COVID-19) testing and support program to mitigate the risk of COVID-19 outbreaks in congregate settings. Clin Infect Dis Off Publ Infect Dis Soc Am 2021;72(9):1639–41. 10.1093/cid/ciaa743. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36. Baggett TP, Scott JA, Le MH et al. Clinical outcomes, costs, and cost-effectiveness of strategies for adults experiencing sheltered homelessness during the COVID-19 pandemic. JAMA Netw Open 2020;3(12):e2028195. 10.1001/jamanetworkopen.2020.28195. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37. Lewer D, Braithwaite I, Bullock M et al. COVID-19 among people experiencing homelessness in England: a modelling study. Lancet Respir Med 2020;8(12):1181–91. 10.1016/S2213-2600(20)30396-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38. Chapman LAC, Kushel M, Cox SN et al. Comparison of infection control strategies to reduce COVID-19 outbreaks in homeless shelters in the United States: a simulation study. BMC Med 2021;19(1):116. 10.1186/s12916-021-01965-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39. Mathieu E, Richie H, Rodés-Guirao L, et al. Canada: Coronavirus Pandemic Country Profile. London: Our World in Data, 2022. https://ourworldindata.org/coronavirus/country/canada (10 October 2022, date last accessed). [Google Scholar]
- 40. Mathieu E, Richie H, Rodés-Guirao L, et al. France: Coronavirus Pandemic Country Profile. Our World in Data, 2022. https://ourworldindata.org/coronavirus/country/france (10 October 2022, date last accessed). [Google Scholar]
- 41. Mathieu E, Richie H, Rodés-Guirao L, et al. United States: Coronavirus Pandemic Country Profile. Our World in Data, 2022. https://ourworldindata.org/coronavirus/country/united-states (10 October 2022, date last accessed). [Google Scholar]
- 42. Mathieu E, Richie H, Rodés-Guirao L, et al. Singapore: Coronavirus Pandemic Country Profile. Our World in Data, 2022. https://ourworldindata.org/coronavirus/country/singapore (10 October 2022, date last accessed). [Google Scholar]
- 43. UN Refugee Agency UK . COVID-19 Pandemic. UNHCR UK, 2023. https://www.unhcr.org/uk/coronavirus-covid-19.html (9 December 2022, date last accessed). [Google Scholar]
- 44. World Health Organization . An Interagency Field Guide: Tuberculosis Prevention and Care Among Refugees and Other Populations in Humanitarian Settings. World Health Organization, 2022. https://www.who.int/publications/i/item/9789240042087 (9 December 2022, date last accessed). [Google Scholar]
- 45. United Nations . High Level Panel on the Development of a Multidimensional Vulnerability Index. United Nations, 2022. https://www.un.org/ohrlls/sites/www.un.org.ohrlls/files/mvi_interim_report.pdf (13 March 2023, date last accessed). [Google Scholar]
- 46. Preventing Exploitation Toolkit . Homelessmess. London: Preventing Exploitation Toolkit, 2023. https://www.preventingexploitationtoolkit.org.uk/ (13 March 2023, date last accessed). [Google Scholar]
- 47. Ralli M, Cedola C, Urbano S et al. Homeless persons and migrants in precarious housing conditions and COVID-19 pandemic: peculiarities and prevention strategies. Eur Rev Med Pharmacol Sci 2020;24(18):9765–7. 10.26355/eurrev_202009_23071. [DOI] [PubMed] [Google Scholar]
- 48. Lasser J, Sorger J, Richter L et al. Assessing the impact of SARS-CoV-2 prevention measures in Austrian schools using agent-based simulations and cluster tracing data. Nat Commun 2022;13(1):554. 10.1038/s41467-022-28170-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49. Führer A, Özer Erdogdu I, Kompa P et al. COVID-19 pandemic in shelters for asylum seekers: a scoping review of preventive measures. BMJ Open 2022;12(4):e058076. 10.1136/bmjopen-2021-058076. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50. TB Alert . Prevention. London: TB Alert, 2022. https://www.tbalert.org/about-tb/what-is-tb/prevention/#:∼:text=The%20risk%20of%20infection%20can,the%20spread%20of%20TB%20bacteria (9 December 2022, date last accessed). [Google Scholar]
- 51. Centers for Disease Control and Prevention . Healthy Habits to Help Protect Against Flu. Centers for Disease Control and Prevention, August 2021. https://www.cdc.gov/flu/prevent/actions-prevent-flu.htm (9 December 2022, date last accessed). [Google Scholar]
- 52. Public Health England . Factors Associated with COVID-19 in Care Homes and Domiciliary Care, and Effectiveness of Interventions: A Rapid Review. Public Health England, 2020. https://ukhsa.koha-ptfs.co.uk/cgi-bin/koha/opac-retrieve-file.pl?id=1bc5eb8d6e5ef9a43c248ef08549ee53 (18 January 2023, date last accessed). [Google Scholar]
- 53. Mathieu E, Richie H, Rodés-Guirao L, et al. COVID-19: Stay-at-Home Restrictions. London: Our World in Data, 2022. https://ourworldindata.org/covid-stay-home-restrictions (10 October 2022, date last accessed). [Google Scholar]
- 54. Jacobsen GD, Jacobsen KH. Statewide COVID-19 stay-at-home orders and population mobility in the United States. World Med Health Policy 2020;12(4):347–56. 10.1002/wmh3.350. [DOI] [PMC free article] [PubMed] [Google Scholar]

